Induced Pluripotent Stem Cells Generated Without Viral Integration
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome-integrating viruses. We generated mouse induced pluripotent stem (iPS) cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c-Myc. These adenoviral iPS (adeno-iPS) cells show DNA demethylation characteristic of reprogrammed cells, express endogenous pluripotency genes, form teratomas, and contribute to multiple tissues, including the germ line, in chimeric mice. Our results provide strong evidence that insertional mutagenesis is not required for in vitro reprogramming. Adenoviral reprogramming may provide an improved method for generating and studying patient-specific stem cells and for comparing embryonic stem cells and iPS cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenovirus and Sendai virus-mediated vector delivery provide alternative non-integrative methods for iPSC reprogramming [24,25,26,27,28].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Self-citationReprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
Dissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,480
Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O., & Jaenisch, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801677105 · Cited by 1,216
Research works printed but not linked: 1
- S. Eminli J. Utikal K. Arnold R. Jaenisch K. Hochedlinger Stem Cells published online 17June2008 in press.
Cited by
Items 401–500 of 1,002
Baker, M. (2009) · Nature · doi:10.1038/458962a · Cited by 57
Amberger, M., & Ivics, Z. (2020) · BioEssays · doi:10.1002/bies.202000136 · Cited by 56
Generation of induced pluripotent stem cells using site-specific integration with phage integrase
Ye, L., Chang, J. C., Lin, C. J., Qi, Z., Yu, J., & Kan, Y. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012677107 · Cited by 56
Pluripotent stem cells and livestock genetic engineering
Soto, D. A., & Ross, P. J. (2016) · Transgenic Research · doi:10.1007/s11248-016-9929-5 · Cited by 56
Pluripotent stem cells and gene therapy
Šimara, P., Motl, J. A., & Kaufman, D. S. (2013) · Translational research · doi:10.1016/j.trsl.2013.01.001 · Cited by 56
Gene targeting from laboratory to livestock: Current status and emerging concepts
Laible, G., & Alonso‐González, L. (2009) · Biotechnology Journal · doi:10.1002/biot.200900006 · Cited by 56
Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells
Yang, C., Al-Aama, J. Y., Stojković, M., Keavney, B. D., Trafford, A. W., Lako, M., & Armstrong, L. (2015) · Stem Cells · doi:10.1002/stem.2070 · Cited by 55
The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells
Brix, J., Zhou, Y., & Luo, Y. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.10.001 · Cited by 55
Furth, M. E., & Atala, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398358-9.00006-9 · Cited by 55
New perspectives in stem cell research: beyond embryonic stem cells
Leeb, C., Jurga, M., McGUCKIN, C. P., Forraz, N., Thallinger, C., Moriggl, R., & Kenner, L. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2010.00725.x · Cited by 55
Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells
Tanaka, A., Yuasa, S., Node, K., & Fukuda, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818894 · Cited by 54
GASPARD, N., & VANDERHAEGHEN, P. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03827.x · Cited by 54
André, E. M., Passirani, C., Seijo, B., Sánchez, A., & Montero‐Menei, C. N. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.008 · Cited by 54
Rony, I. K., Baten, A., Bloomfield, J. A., Islam, M. E., Billah, M. M., & Islam, K. M. D. (2015) · Cell Proliferation · doi:10.1111/cpr.12162 · Cited by 54
Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis
Barczyk, M., Schmidt, M., & Mattoli, S. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9587-7 · Cited by 54
Cellular Reprogramming Using Protein and Cell-Penetrating Peptides
Seo, B. J., Hong, Y. J., & Do, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030552 · Cited by 54
Reprogrammed Pluripotent Stem Cells from Somatic Cells
Kim, J. S., Choi, H. W., Choi, S., & Tae, J. (2011) · International Journal of Stem Cells · doi:10.15283/ijsc.2011.4.1.1 · Cited by 54
Recent technological updates and clinical applications of induced pluripotent stem cells
Diecke, S., Jung, S. M., Lee, J., & Ju, J. H. (2014) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2014.29.5.547 · Cited by 53
Stem cells: novel players in the treatment of erectile dysfunction
Zhang, H., Albersen, M., Jin, X., & Lin, G. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2011.79 · Cited by 53
Glotzbach, J. P., Wong, V., Gurtner, G. C., & Longaker, M. T. (2011) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2010.11.002 · Cited by 53
Ye, H., & Wang, Q. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494589 · Cited by 53
Belay, E., Mátrai, J., Acosta‐Sanchez, A., Ma, L., Quattrocelli, M., Mátés, L., Sancho‐Bru, P., Geraerts, M., Yan, B., Vermeesch, J. R., et al. (2010) · Stem Cells · doi:10.1002/stem.501 · Cited by 53
Generation of functional hepatocytes from mouse induced pluripotent stem cells
Li, W., Wang, D., Qin, J., Liu, C., Zhang, Q., Zhang, X., Yu, X., Lahn, B. T., Mao, F. F., & Xiang, A. P. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.22000 · Cited by 52
Stem Cell Therapies for Treatment of Liver Disease
Nicolas, C. T., Wang, Y., Luebke-Wheeler, J. L., & Nyberg, S. L. (2016) · Biomedicines · doi:10.3390/biomedicines4010002 · Cited by 52
The march of pluripotent stem cells in cardiovascular regenerative medicine
Abou-Saleh, H., Zouein, F. A., EL‐Yazbi, A. F., Sanoudou, D., Raynaud, C. M., Rao, C., Pintus, G., Dehaini, H., & Eid, A. H. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0947-5 · Cited by 52
Raabe, F. J., Galinski, S., Papiol, S., Falkai, P., Schmitt, A., & Rossner, M. J. (2018) · Schizophrenia · doi:10.1038/s41537-018-0066-4 · Cited by 52
Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders
Wattanapanitch, M. (2019) · Stem Cells International · doi:10.1155/2019/5171032 · Cited by 52
Cellular Reprogramming Employing Recombinant Sox2 Protein
Thier, M. C., Münst, B., Mielke, S., & Edenhofer, F. (2012) · Stem Cells International · doi:10.1155/2012/549846 · Cited by 52
Cieślar‐Pobuda, A., Rafat, M., Knoflach, V., Skonieczna, M., Hudecki, A., Małecki, A., Urasińska, E., Ghavami, S., & Łoś, M. (2016) · Oncotarget · doi:10.18632/oncotarget.9791 · Cited by 52
Induced human pluripotent stem cells: promises and open questions
Rolletschek, A., & Wobus, A. M. (2009) · Biological Chemistry · doi:10.1515/bc.2009.103 · Cited by 52
Bakhshandeh, B., Soleimani, M., Hafizi, M., & Ghaemi, N. (2012) · Cytotechnology · doi:10.1007/s10616-012-9430-9 · Cited by 52
The evolving field of induced pluripotency: Recent progress and future challenges
Sommer, C., & Mostoslavsky, G. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24155 · Cited by 51
Controlling the Stem Cell Compartment and Regeneration In Vivo: The Role of Pluripotency Pathways
Greenow, K. R., & Clarke, A. R. (2012) · Physiological Reviews · doi:10.1152/physrev.00040.2010 · Cited by 51
Bioethics and the Future of Stem Cell Research
Hyun, I. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511816031 · Cited by 51
Evolution of induced pluripotent stem cell technology
Zhou, H., & Ding, S. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328339f2ee · Cited by 51
Induced Pluripotent Stem Cells: Emerging Techniques for Nuclear Reprogramming
Han, J. W., & Yoon, Y. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3814 · Cited by 51
p53 switches off pluripotency on differentiation
Lin, T., & Lin, Y. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0498-1 · Cited by 51
Non-Viral Generation of Marmoset Monkey iPS Cells by a Six-Factor-in-One-Vector Approach
Debowski, K., Warthemann, R., Lentes, J., Salinas, G., Dressel, R., Langenstroth, D., Gromoll, J., Sasaki, E., & Behr, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118424 · Cited by 51
Fan, Y., Luo, Y., Chen, X., Li, Q., & Sun, X. (2012) · Journal of Reproduction and Development · doi:10.1262/jrd.2011-046 · Cited by 51
Instructing an Embryonic Stem Cell-Derived Oocyte Fate: Lessons from Endogenous Oogenesis
Nicholas, C. R., Chavez, S. L., Baker, V. L., & Pera, R. A. R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0034 · Cited by 51
Pluripotent cells in farm animals: state of the art and future perspectives
Nowak‐Imialek, M., & Niemann, H. (2012) · Reproduction Fertility and Development · doi:10.1071/rd12265 · Cited by 50
Pluripotent stem cells to hepatocytes, the journey so far
Palakkan, A. A., Nanda, J., & Ross, J. A. (2017) · Biomedical Reports · doi:10.3892/br.2017.867 · Cited by 50
Targeting LRRK2 in Parkinson’s disease: an update on recent developments
Chan, S. L., & Tan, E.-K. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1323881 · Cited by 50
The evolving biology of cell reprogramming
Wilmut, I., Sullivan, G. J., & Chambers, I. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0051 · Cited by 50
In vitro neurogenesis: development and functional implications of iPSC technology
Compagnucci, C., Nizzardo, M., Corti, S. P., Zanni, G., & Bertini, E. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1511-1 · Cited by 50
Current Applications of Human Pluripotent Stem Cells: Possibilities and Challenges
Ho, P.-J., Yen, M., Yet, S., & Yen, B. L. (2012) · Cell Transplantation · doi:10.3727/096368911x627507 · Cited by 50
Tumors Originating from Induced Pluripotent Stem Cells and Methods for Their Prevention
Duinsbergen, D., Salvatori, D. C. F., Eriksson, M., & Mikkers, H. M. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04563.x · Cited by 50
Stem Cell-Based Therapeutics to Improve Wound Healing
Hu, M. S.-M., Leavitt, T., Malhotra, S., Duscher, D., Pollhammer, M. S., Walmsley, G. G., Maan, Z. N., Cheung, A. T. M., Schmidt, M., Huemer, G. M., et al. (2015) · Plastic Surgery International · doi:10.1155/2015/383581 · Cited by 50
Spermatogonial stem cells: unlimited potential
Dym, M., He, Z., Jiang, J., Pant, D., & Kokkinaki, M. (2008) · Reproduction Fertility and Development · doi:10.1071/rd08221 · Cited by 50
Applications of 3D Bioprinting Technology in Induced Pluripotent Stem Cells-Based Tissue Engineering
Shukla, A. K., Gao, G., & Kim, B. S. (2022) · Micromachines · doi:10.3390/mi13020155 · Cited by 49
Myocardial therapeutic angiogenesis: a review of the state of development and future obstacles
Robich, M. P., Chu, L. M., Oyamada, S., Sodha, N. R., & Sellke, F. W. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.148 · Cited by 49
A realistic appraisal of the use of embryonic stem cell-based therapies for cardiac repair
Wysoczynski, M., & Bolli, R. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz787 · Cited by 49
Yang, D. Y., Yu, D., Dou, D., Ropper, Alexander, E., Li, Jianxue, Kabataş, S., Serdar, Wakeman, et al. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376299 · Cited by 49
Stem cells for cardiac repair: an introduction.
du Pré, B. C., Doevendans, P. A., & Laake, L. W. V. (2013) · PubMed Central · doi:10.3969/j.issn.1671-5411.2013.02.003 · Cited by 49
Fu, W. E., Wang, S., Zhou, G. D., Liu, W., Cao, Y., & Zhang, W. J. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0131 · Cited by 49
Ishikawa, M., Ohnishi, H., Skerleva, D., Sakamoto, T., Yamamoto, N., Hotta, A., Ito, J., & Nakagawa, T. (2015) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2072 · Cited by 49
Pluripotent stem cells: induction and self-renewal
Abu‐Dawud, R., Graffmann, N., Ferber, S., Wruck, W., & Adjaye, J. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0213 · Cited by 48
Pluripotency and Nuclear Reprogramming
Déjosez, M., & Zwaka, T. P. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052709-104948 · Cited by 48
Winkler, T., Cantilena, A. R., Métais, J., Xu, X., Nguyen, A., Borate, B. R., Antosiewicz‐Bourget, J., Wolfsberg, T. G., Thomson, J. A., & Dunbar, C. E. (2010) · Stem Cells · doi:10.1002/stem.322 · Cited by 48
Concise Review: Alchemy of Biology: Generating Desired Cell Types from Abundant and Accessible Cells
Pournasr, B., Khalooghi, K., Salekdeh, G. H., Totonchi, M., Shahbazi, E., & Baharvand, H. (2011) · Stem Cells · doi:10.1002/stem.760 · Cited by 48
The expanding horizon of MicroRNAs in cellular reprogramming
Adlakha, Y. K., & Seth, P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.11.003 · Cited by 48
Advancements in reprogramming strategies for the generation of induced pluripotent stem cells
Lai, M. I., Wendy-Yeo, W. Y., Ramasamy, R., Nordin, N., Rosli, R., Veerakumarasivam, A., & Abdullah, S. (2011) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-011-9552-6 · Cited by 48
Pennarossa, G., Maffei, S., Campagnol, M., Rahman, M. M., Brevini, T., & Gandolfi, F. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9477-9 · Cited by 48
Matteo, M. D., Mátrai, J., Belay, E., Firdissa, T., VandenDriessche, T., & Chuah, M. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-603-6_14 · Cited by 48
Patient-Specific Pluripotent Stem Cells in Neurological Diseases
Durnaoglu, S., Genç, Ş., & Genç, K. (2011) · Stem Cells International · doi:10.4061/2011/212487 · Cited by 47
Induced neural stem cells: Methods of reprogramming and potential therapeutic applications
Ruggieri, M., Riboldi, G. M., Brajkovic, S., Bucchia, M., Bresolin, N., Comi, G. P., & Corti, S. P. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.001 · Cited by 47
Lee, J. E., Kang, M. S., Park, M. H., Shim, S. H., Yoon, T. K., Chung, H., & Lee, D. R. (2010) · Cell Transplantation · doi:10.3727/096368910x513991 · Cited by 47
Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy
Danišovič, Ľ., Culenova, M., & Csöbönyeiová, M. (2018) · Cells · doi:10.3390/cells7120253 · Cited by 47
Experimental approaches for the generation of induced pluripotent stem cells
Sommer, C., & Mostoslavsky, G. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt26 · Cited by 47
Ogliari, K. S., Marinowic, D. R., Brum, D. E. D. L., & Loth, F. (2014) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20142530 · Cited by 47
Molecular marks for epigenetic identification of developmental and cancer stem cells
Patra, S. K., Deb, M., & Patra, A. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0016-0 · Cited by 46
iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery
Zhang, R., Zhang, L., & Xie, X. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.21 · Cited by 46
Genome modification in human embryonic stem cells
Tenzen, T., Zembowicz, F., & Cowan, C. A. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21948 · Cited by 45
In Vivo Cell Reprogramming towards Pluripotency by Virus-Free Overexpression of Defined Factors
Yilmazer, A., de Lázaro, I., Bussy, C., & Kostarelos, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054754 · Cited by 45
Looking to the future following 10 years of induced pluripotent stem cell technologies
Li, M., & Belmonte, J. C. I. (2016) · Nature Protocols · doi:10.1038/nprot.2016.108 · Cited by 45
Engineering-derived approaches for iPSC preparation, expansion, differentiation and applications
Li, Y., Li, L., Chen, Z., Gao, G., Yao, R., & Sun, W. (2017) · Biofabrication · doi:10.1088/1758-5090/aa7e9a · Cited by 45
Tricot, T., Verfaillie, C. M., & Kumar, M. (2022) · Cells · doi:10.3390/cells11030442 · Cited by 45
Steinle, H., Weber, M., Behring, A., Mau-Holzmann, U. A., OHLE, C. V., Popov, A., Schlensak, C., Wendel, H. P., & Avci‐Adali, M. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.07.016 · Cited by 45
Pluripotent Reprogramming of Fibroblasts by Lentiviralmediated Insertion of SOX2, C-MYC, and TCL-1A
Picanço‐Castro, V., Russo, E. M. D. S., Reis, L. C. J., Fraga, A. M., Magalhães, D. A., Orellana, M. D., Panepucci, R. A., Pereira, L. V., & Covas, D. T. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0424 · Cited by 45
Induced pluripotent stem cells generated without viral integration†
Eggenschwiler, R., Cantz, T., Kowdley, K. V., McCaughan, G. W., & Trautwein, C. (2009) · Hepatology · doi:10.1002/hep.22827 · Cited by 45
Red blood cells from induced pluripotent stem cells: hurdles and developments
Mazurier, C., Douay, L., & Lapillonne, H. (2011) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283476129 · Cited by 45
Valproic acid enhances Oct4 promoter activity in myogenic cells
Teng, H. F., Kuo, Y., Loo, M. R., Li, C. L., Chu, T. W., Suo, H., Liu, H. S., Lin, K., & Chen, S. L. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22613 · Cited by 45
Current and Future Perspectives of Stem Cell Therapy in Dermatology
Prodinger, C. M., Reichelt, J., Bauer, J. W., & Laimer, M. (2017) · Annals of Dermatology · doi:10.5021/ad.2017.29.6.667 · Cited by 45
Pluripotent Stem Cells for Schwann Cell Engineering
Ma, M., Boddeke, E., & Copray, S. C. V. M. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9577-1 · Cited by 45
Emerging Methods for Preparing iPS Cells
Miyazaki, S., Yamamoto, H., Miyoshi, N., Takahashi, H., Suzuki, Y., Haraguchi, N., Ishii, H., Doki, Y., & Mori, M. (2012) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hys108 · Cited by 45
Nezhad, M. S., Abdollahpour‐Alitappeh, M., Rezaei, B., Yazdanifar, M., & Seifalian, A. M. (2021) · Pharmaceutical Research · doi:10.1007/s11095-021-03067-z · Cited by 44
Stress-mediated p38 activation promotes somatic cell reprogramming
Xu, X., Wang, Q., Long, Y., Zhang, R., Wei, X., Xing, M., Gu, H., & Xie, X. (2012) · Cell Research · doi:10.1038/cr.2012.143 · Cited by 44
The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk
Kumar, K. K., Aboud, A. A., & Bowman, A. B. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.02.005 · Cited by 44
Haake, K., Ackermann, M., & Lachmann, N. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0134 · Cited by 44
Chhabra, A. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9766-9 · Cited by 44
Roadblocks en route to the clinical application of induced pluripotent stem cells
Lowry, W. E., & Quan, W. L. (2010) · Journal of Cell Science · doi:10.1242/jcs.054304 · Cited by 43
Balasubramanian, S., Babai, N. Z., Chaudhuri, A., Qiu, F., Bhattacharya, S., Davé, B. J., Parameswaran, S., Carson, S. D., Thoreson, W. B., Sharp, J. G., et al. (2009) · Stem Cells · doi:10.1002/stem.242 · Cited by 43
Generation of Mouse Induced Pluripotent Stem Cells by Protein Transduction
Nemes, C., Varga, E., Polgár, Z., Klincumhom, N., Pirity, M. K., & Dinnyés, A. (2013) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2013.0026 · Cited by 43
Differentiating human stem cells into neurons and glial cells for neural repair
Selvaraj, V., Jiang, P., Chechneva, O., Lo, U., & Deng, W. (2011) · Frontiers in bioscience · doi:10.2741/3916 · Cited by 43
Földes, A., Kádár, K., Kerémi, B., Zsembery, Á., Gyires, K., Zádori, Z., & Varga, G. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160121115210 · Cited by 43
Current status of treating neurodegenerative disease with induced pluripotent stem cells
Pen, A. E., & Jensen, U. B. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12545 · Cited by 43
Induction of fibroblasts to neurons through adenoviral gene delivery
Meng, F., Chen, S., Miao, Q., Zhou, K., Lao, Q., Zhang, X. H., Guo, W., & Jiao, J. (2011) · Cell Research · doi:10.1038/cr.2011.185 · Cited by 43
Reprogramming Therapeutics: iPS Cell Prospects for Neurodegenerative Disease
Abeliovich, A., & Doege, C. A. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.024 · Cited by 43
The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases
Hansel, M. C., Davila, J. C., Vosough, M., Gramignoli, R., Skvorak, K. J., Dorko, K., Marongiu, F., Blake, W. L., & Strom, S. C. (2016) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx1413s67 · Cited by 43
Feeder‐Free Reprogramming of Human Fibroblasts with Messenger RNA
Warren, L. A., & Wang, J. (2013) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc04a06s27 · Cited by 43
Metadata
- Authors
- Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- Hochedlinger, Konrad
- Venue
- Science
- Published
- 2008-11-07
- Volume
- 322
- Issue
- 5903
- Pages
- 945-949
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3987909
- OpenAlex
- W2050689355
- Cited by
- 1,683
- References
- 29
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 33 · 2023: 22 · 2022: 32 · 2021: 55 · 2020: 50 · 2019: 38 · 2018: 63 · 2017: 63 · 2016: 104 · 2015: 105 · 2014: 139 · 2013: 161 · 2012: 185
- FWCI
- 82.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1dp2od003266-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- induced pluripotent stem cells, Oct4, SOX2, KLF4, c-Myc, somatic cell reprogramming, DNA demethylation, teratoma, chimeric mice, fibroblasts, hepatocytes, insertional mutagenesis, patient-derived stem cells, embryonic stem cells
- MeSH terms
- Kruppel-Like Factor 4, Adenoviridae, Animals, Cell Differentiation, Cell Line, Chimera, Cloning, Molecular, Female, Fibroblasts, Genetic Vectors, Liver, Male, Teratoma, Genes, myc, Proto-Oncogene Proteins c-myc, Mice, SCID, Virus Integration, Transgenes, Hepatocytes, Pluripotent Stem Cells, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.